Literature DB >> 11054669

Induced neuroblastoma cell differentiation, associated with transient HES-1 activity and reduced HASH-1 expression, is inhibited by Notch1.

A Grynfeld1, S Påhlman, H Axelson.   

Abstract

Neuroblastoma is a childhood tumor that originates from the sympathetic nervous system. The tumor cells have embryonic features, presumably as a consequence of an impaired capacity to respond to signals and transcriptional control mechanisms operating during normal differentiation. Two basic helix-loop-helix transcription factors, human achaete-scute homologue-1 (HASH-1) and hairy/enhancer of split homologue-1 (HES-1), are crucial for proper development of some neuronal cells. Here, their potential roles during sympathetic differentiation of human neuroblastoma cells have been investigated. In all tested protocols for induction of differentiation of SH-SY5Y and SK-N-BE(2) neuroblastoma cells, HASH-1 expression was rapidly decreased with a concomitant, often transient, increase in HES-1 expression. In gel mobility shift assays, using extracts from neuroblastoma cells, HES-1 bound to an oligonucleotide corresponding to a sequence in the HASH-1 promoter including the so-called N-box, suggesting that the transiently increased HES-1 activity in differentiating neuroblastoma cells is involved in down-regulation of HASH-1. Constitutive expression of the intracellular domain of Notch1, which activates the HES-1 promoter in SH-SY5Y cells, inhibited spontaneous and induced morphological differentiation of these neuroblastoma cells. Our data show that functional sympathetic neuronal differentiation of neuroblastoma cells is associated with transient activation of HES-1 and down-regulation of HASH-1 expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054669

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  Hes1: a key role in stemness, metastasis and multidrug resistance.

Authors:  Zi-Hao Liu; Xiao-Meng Dai; Bin Du
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Activation of Notch signal pathway is associated with a poorer prognosis in acute myeloid leukemia.

Authors:  Xin Xu; Yu Zhao; Maozhong Xu; Qiuxin Dai; Wenjun Meng; Jiangang Yang; Rujuan Qin
Journal:  Med Oncol       Date:  2010-09-02       Impact factor: 3.064

3.  Notch pathway activation induces neuroblastoma tumor cell growth arrest.

Authors:  Peter E Zage; Riitta Nolo; Wendy Fang; John Stewart; Guillermo Garcia-Manero; Patrick A Zweidler-McKay
Journal:  Pediatr Blood Cancer       Date:  2011-07-08       Impact factor: 3.167

4.  Synergistic efficacy of a novel combination therapy controls growth of Bcl-x(L) bountiful neuroblastoma cells by increasing differentiation and apoptosis.

Authors:  Nishant Mohan; Naren L Banik; Swapan K Ray
Journal:  Cancer Biol Ther       Date:  2011-11-01       Impact factor: 4.742

5.  Valproic acid enhances neuronal differentiation of sympathoadrenal progenitor cells.

Authors:  V Vukićević; N Qin; M Balyura; G Eisenhofer; M L Wong; J Licinio; S R Bornstein; M Ehrhart-Bornstein
Journal:  Mol Psychiatry       Date:  2015-02-24       Impact factor: 15.992

Review 6.  Notch signaling in pediatric malignancies.

Authors:  Patrick A Zweidler-McKay
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

7.  Inhibition of Notch signaling facilitates the differentiation of human-induced pluripotent stem cells into neural stem cells.

Authors:  Chun-Yuan Chen; Wei Liao; Yuan-Lei Lou; Qing Li; Bin Hu; Yang Wang; Zhi-Feng Deng
Journal:  Mol Cell Biochem       Date:  2014-06-28       Impact factor: 3.396

8.  HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells.

Authors:  Alexander Pietras; Loen M Hansford; A Sofie Johnsson; Esther Bridges; Jonas Sjölund; David Gisselsson; Matilda Rehn; Siv Beckman; Rosa Noguera; Samuel Navarro; Jörg Cammenga; Erik Fredlund; David R Kaplan; Sven Påhlman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-16       Impact factor: 11.205

9.  Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation.

Authors:  Johan Hartman; Eric W-F Lam; Jan-Ake Gustafsson; Anders Ström
Journal:  Breast Cancer Res       Date:  2009-11-05       Impact factor: 6.466

Review 10.  Main roads to melanoma.

Authors:  Giuseppe Palmieri; Mariaelena Capone; Maria Libera Ascierto; Giusy Gentilcore; David F Stroncek; Milena Casula; Maria Cristina Sini; Marco Palla; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.